Rijksinstituut voor Volksgezondheid en Milieu
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study. | RIVM
Bron:
rivm.nl